The Vav family is a group of signal transduction molecules with oncogenic potential that play important roles in development and cell signaling. Members of this family are distributed in all animal metazoans but not in unicellular organisms. Recent genomic studies suggest that the function of Vav proteins co-evolved with tyrosine kinase pathways, probably to assure the optimal conversion of extracellular signals into biological responses coupled to the cytoskeleton and gene transcription. To date, the best-known function of Vav proteins is their role as GDP/GTP exchange factors for Rho/Rac molecules, a function strictly controlled by tyrosine phosphorylation. Recent publications indicate that this function is highly dependent on the interaction of adaptor proteins that aid in the proper phosphorylation of Vav proteins, their interaction with other signaling molecules, and in modulating the strength of their signal outputs. In addition to the function of Vav proteins as exchange factors, there is increasing evidence suggesting that Vav proteins can mediate other cellular functions independently of their exchange activities, probably by working themselves as adaptor molecules. In this review, we will give a summary of the recent advances in this ®eld, placing special emphasis on the non-catalytic roles of Vav and its interaction with other adaptor molecules. Oncogene (2001) 20, 6372 ± 6381.
Introduction
The evolutionary transition of unicellular to multicellular animal organisms coincided with the development of signal transduction pathways regulated by tyrosine phosphorylation events. With the advent of membrane and cytoplasmic tyrosine kinases, other signaling proteins evolved to couple the activation of those enzymes with downstream eectors. These new cellular functions led in turn to the formation of new structural domains, one of which, the Src-homology 2 (SH2) domain, was especially successful due to its exibility and adaptability to multiple functions. This domain is involved in a large number of regulatory roles, ranging from the tethering of signaling molecules to speci®c subcellular localizations, the activation/inactivation of proteins, and the facilitation of homo and heteromerization processes There has been a traditional classi®cation of SH2-containing proteins depending on the presence of recognizable catalytic domains. The proteins lacking them were termed`adaptor' molecules, since it was assumed they worked as bridge molecules, allowing the indirect interaction of tyrosine kinase receptors with eector molecules lacking SH2 domains. The best-known example of this type of SH2-containing molecules is Grb2, a protein that binds simultaneously to activated receptors via its SH2 domain and to the Ras exchange factor Son-of-Sevenless (SOS) through its SH3 domains. However, as the characterization of the functional roles of SH2-containing proteins progresses, the initial distinction between catalytic and adaptor SH2-containing proteins is blurring. For instance, it is now known that many enzymes may also work as adaptor molecules due to their multidomain structure. On the other hand, some proteins originally regarded as`adaptor' molecules were found later on to have enzymatic functions after the discovery of new catalytic domains.
One group of proteins that best exempli®es the inadequacy in this classi®cation and the multiple roles of adaptor molecules in cell signaling is the Vav family. It is well known now that these proteins act as guanosine nucleotide exchange factors (GEFs) for Rho/Rac proteins. However, some biological roles recently discovered for these proteins cannot be clearly linked to this function, suggesting that Vav proteins may also act as adaptor molecules. In addition, there is accumulating evidence indicating the importance of adaptor proteins in the regulation of Vav proteins at dierent levels. Given the monographic focus of this issue in the function of adaptor proteins, we will pay attention to this particular aspect of Vav family regulation and function. Other areas of Vav family function were covered extensively in a recent publication (Bustelo, 2000) .
Vav proteins: catalytic and adaptor functions?
The Vav family has currently three known members in mammalian cells (Vav, Vav2, and Vav3) , and two in invertebrates (C. elegans Vav and D. melanogaster Vav). In addition, cDNA EST clones encoding fragments of Vav-like proteins are found in X. laevis, D. rerio (zebra ®sh), I. punctatus (cat ®sh) and S. stercoralis (a nematode) (http://www3.ncbi.nlm.nih. gov/htbin-post/Entrez/query?db= 2&form = 1&term= vav). Vav proteins are not present in yeast despite the presence of Rho GTPases and Rho GEFs in these cells. Vav family members share a similar structure ( Figure  1a ). Mammalian Vav proteins contain a calponinhomology (CH) domain, an acidic (Ac) region, the Dbl-(DH) and plekstrin-homology (PH) domains typical of members of Rho GEFs, a zinc ®nger (ZF) domain, and two SH3 domains¯anking a single SH2 region. The nematode Vav protein diers mostly at the C-terminus, where it lacks the two SH3 domains present in mammalian Vav proteins (Figure 1a ). In addition, its ZF region appears to be non-functional due to the absence of key cysteine residues important for the folding of the domain. The structure of D. melanogaster Vav is better conserved, lacking only the most N-terminal SH3 domain (Figure 1a) . Although all the structural domains present in Vav proteins are commonly found in many signal transduction molecules, the Vav family is unique in having the DH-PH cassette coupled to a ZF region and to a SH2 region. The spatial organization of the C-terminal SH3 and SH2 of the mammalian Vav proteins is also unusual among other proteins, being only present in Grb2-related proteins such as Grb and Grab/Grap proteins.
The best-characterized function of Vav proteins is their activity as guanosine nucleotide exchange factors for Rho/Rac proteins (Crespo et al., 1997; Han et al., 1997; Movilla and Bustelo, 1999; Schuebel et al., 1998) . This enzyme activity catalyzes the release of GDP from the inactive GTPases, a step that favors the subsequent incorporation of GTP and the acquisition by the GTPases of active conformations capable of interacting with eector molecules. In addition, this conformational change releases the inhibitory Rho GDI molecules associated to GDPbound Rho/Rac proteins, an event that allows the translocation of the GTPases to the plasma membrane. The biological consequences of the exchange activity of Vav proteins have been reviewed recently (Bustelo, 2000) .
Although there are now more than forty exchange factors known for Rho/Rac proteins in humans, the distinctive functional feature of the Vav family is that their catalytic activity is modulated by direct tyrosine phosphorylation (Crespo et al., 1997; Han et al., 1997; Movilla and Bustelo, 1999; Schuebel et al., 1998) . NMR studies have revealed that the structural mechanism for Vav activation relies on the release of an autoinhibitory loop nucleated around a tyrosine residue located in the acidic region of Vav (Y174) (Aghazadeh et al., 2000) . In the non-phosphorylated state, this residue makes contacts with the side chains of residues located in the Rac1 binding domain of the Vav catalytic region (Y209, T212, P320, L325, V328), leading to the formation of a`closed' con®guration of the molecule incapable of interacting with its substrate (Aghazadeh et al., 2000) . The phosphorylation of Y174 leads to a steric clash of the incorporated phosphate group with the side chains of residues present in the DH region of Vav (R332, Y209), leading to an`open' con®guration of the exchange factor capable of making stable interactions with Rac1 (Aghazadeh et al., 2000) . The residue located at position 174 of Vav and its surrounding amino acid sequences are conserved in the three mammalian Vav members and in D. melanogaster Vav, suggesting that this regulatory mechanism is taking place in most Vav family members. It is not presently known whether this is the exclusive mechanism for the phosphorylation-dependent activation of Vav proteins. In this respect, it is possible that other intramolecular interactions mediated by the most Nterminal CH region could contribute to this auto- (Katzav et al., 1989; Schuebel et al., 1998) . Whether phosphorylation plays alternative functional roles in the regulation of the Vav pathway remains to be fully established. In this context, it has been suggested that three tyrosine residues of the Vav acidic domain could also induce the downmodulation of active Vav, probably by attracting some inhibitory phosphotyrosine binding proteins Kuhne et al., 2000; Lopez-Lago et al., 2000) . Due to this, Vav proteins with Y to F mutations in residues 174, 140 and 162 are more active than wild type Vav in a number of biological assays Kuhne et al., 2000; Lopez-Lago et al., 2000) . In addition to this putative inhibitory role, it is possible that other phosphotyrosine residues could serve as docking sites for other signaling proteins, thus allowing the engagement of parallel or synergistic pathways to those activated by Rho/Rac GTPases. At this moment, however, this alternative role for tyrosine phosphorylation remains hypothetical.
Vav proteins also become activated by mutations triggering their latent oncogenic activity. Such mutations include deletions in the CH alone, the CH plus the acidic domain, or point mutations in the inhibitory residue Y174 (Katzav et al., 1989; Lopez-Lago et al., 2000; Schuebel et al., 1998) . In this case, there is a synergistic eect when this mutation is combined with mutations in tyrosine residues located at positions 142 or 160 (numbered according to the sequence of mouse Vav) (Lopez-Lago et al., 2000) . So far, no other genetic alterations in these proteins were correlated with the activation of the oncogenic activity of Vav. All these oncogenic mutants lead to the hyperactivation of the Rho/Rac pathway, as tested in a number of biological assays such as cytoskeletal organization, activation of kinase cascades, and stimulation of transcriptional factors (Bustelo, 2000) .
Interestingly, one of the ®rst roles attributed to Vav was its function as an adaptor molecule, given the presence of an SH3-SH2-SH3 cassette and, at that time, the absence of any recognizable catalytic motif within its structure. After the discovery of the Vav DH domain and of its exchange activity towards Rho/Rac GTPases (Crespo et al., 1997) , most of the subsequent biological studies focused on the role of this protein as a Rac1 GEF. However, as new biological roles for Vav proteins are unveiled, it is clear that the stimulation of the Rho/Rac pathway cannot explain many of the biological eects mediated by Vav proteins. These additional functions appear to be restricted so far to the realm of hematopoietic cells. In T-and Blymphocytes, Vav proteins can stimulate the transcription of the interleukin 2 (il-2) gene proximal promoter via the activation of the transcription factor NF-AT (an acronym for Nuclear Factor of Activated T-cells). In addition, Vav proteins induce the generation of more robust calcium¯uxes in stimulated lymphocytes. These functions have been ®rmly established both by overexpression studies in cell lines and by loss-offunction mutations using gene targeting experiments Costello et al., 1999; Fischer et al., 1995 Fischer et al., , 1998 Turner et al., 1997; Wu et al., 1995) . These two functions are probably intertwined during signal transduction, given the known connection between Ca 2+¯u xes and NF-AT activation in lymphocytes (Ser¯ing et al., 2000; Zhu and McKeon, 2000) . There is recent evidence indicating that this biological response includes Rho/Rac-independent steps. First, oncogenic mutants of Vav with deletions in the CH region that activate the Rac1 pathway cannot trigger either of these two responses (LopezLago et al., 2000; Wu et al., 1995) . Secondly, Weiss' group has demonstrated that a catalytically inactive version of Vav is still capable of inducing NF-AT activation despite any detectable levels of GTP-bound Rac1 in these cells (Kuhne et al., 2000) . It should be noted however that this result depends on the type of DH mutant used, since Vav proteins with a L213Q/F mutation cannot trigger NF-AT activation (Doody et al., 2000; our unpublished observations) . The reason for this discrepancy is still unknown. Finally, it is known that constitutively active versions of Rac1, RhoA or Cdc42 cannot stimulate NF-AT or Ca 2+ uxes per se (Holsinger et al., 1998) . If the catalytic domains of Vav proteins are not involved in these two biological processes, how is this response assembled during signal transduction in a stimulus-regulated manner? The answer to this question is dicult due to the complexity of the NF-AT pathway in T-cells. This transcriptional factor becomes activated by the conversion of three independent pathways that mediate both its subcellular localization and transcriptional activity (Ser¯ing et al., 2000; Zhu and McKeon, 2000) . First, NF-AT activation requires the generation of Ca 2+¯u xes that mediate the activation of calcineurin. This molecule is a Ca 2+ -dependent serine phosphatase that dephosphorylates NF-AT molecules in a cluster of serine residues, a necessary step for the translocation of this transcriptional factor to the nucleus. Once in the nucleus, NF-AT requires the help of converging signals from the Rac1 and Ras pathways for the transcriptional activation of target genes (Ser¯ing et al., 2000; Zhu and McKeon, 2000) . Fragmentary evidence indicates that Vav protein can impinge on NF-AT function at dierent levels: (i) changes in the cytoskeleton; (ii) activation of calcium¯uxes; (iii) activation of the Ras pathway; (iv) other adaptor proteins (Figure 2 ). These levels of regulation are discussed below.
Using the Rac1 pathway, Vav impacts on the NF-AT route by inducing changes in the cytoskeleton that are subsequently translated into the activation of NF-AT by an as yet unknown mechanism (Figure 2 ). This action is inferred from experiments performed with Tcells demonstrating that the chemical inhibition of actin polymerization induces defects in NF-AT responses similar to those found in vav (7/7) cells (Holsinger et al., 1998) . This pathway of NF-AT activation is independent of Ca 2+ , since the inhibition response of stimulated T-cells (Holsinger et al., 1998) . The Vav/Rac1 pathway also induces the activation of members of the NFkB family (Costello et al., 1999) , a group of transcriptional factors that cooperate at the promoter level with NF-AT (Figure 2 ). If this route is important in NF-AT regulation, it should be expected that the future analysis of T-cells de®cient for Rho/Rac GTPases would have similar defects in NF-AT activation.
Vav appears also to regulate the NF-AT pathway at the level of nuclear translocation by modulating the generation of Ca 2+¯u xes during the stimulation of lymphocytes (Figure 2) . The mechanism by which Vav promotes Ca 2+ in lymphoid cells is uncertain and, probably, involves cell type-speci®c mechanisms. Using knock out animals, Tybulewicz's group has shown that TCR-stimulated vav (7/7) T-cells have impaired production of inositol triphosphate (IP 3 ), indicating that the absence of Ca 2+¯u xes in T-cells is probably derived from an inecient phospholipase C-g1 (PLCg1) function (Costello et al., 1999) . PLC-g1 phosphorylation is normal in these cells, suggesting that Vav modulates PLC-g1 using a dierent pathway (Costello et al., 1999) . There are two possible, although not mutually exclusive, mechanisms for such regulation. Since Vav proteins can bind to the regulatory subunit (p85) of phosphatidylinositol-3-OH kinase (PI3-K) (Weng et al., 1994; Zeng et al., 2000) , one possibility is that Vav could induce the translocation of PLC-g1 to the plasma membrane via the generation of PI3-K products. In this respect, it has been shown that phosphatidylinositol 3,4,5-trisphosphate (PIP 3 ) can trigger such translocation by interacting with the PH (Falasca et al., 1998) . Despite the obvious attractiveness of this model, there are no data available demonstrating the association of PI3-K activity with Vav during cell signaling nor on the levels of PI3-K activity in stimulated vav (7/7) Tcells. In addition, the interaction of Vav with p85 is not always detected, indicating that the anity of the interaction is very weak (our unpublished observations). An alternative mechanism for the regulation of PLC-g1 is by facilitating the availability of PIP 2 , the PLC-g1 substrate. This can be achieved via the stimulation of PIP-5 kinase, a Rac1 downstream element (Ren and Schwartz, 1998) (Figure 2 ). Although PIP 2 is present in the plasma membrane of naõÈ ve cells, it is assumed that the continuous regeneration of the PIP 2 pool is important to maintain the enzyme reaction catalyzed by PLC-g1 during the course of cell signaling (Ren and Schwartz, 1998) .
Although all these routes may play a role in the biological response of Vav protein in T-cells, indirect evidence indicates that this second messenger-dependent eect cannot account for the overall Ca 2+ and NF-AT signal mediated by Vav. Thus, if the Rac1 pathway were the important one for this response, it could be expected that the oncogenic forms of Vav would lead to both enhanced Ca 2+ production and NF-AT activation. However, these forms are totally inactive in these responses despite being capable of inducing high levels of activation of Rac1 downstream elements such as JNK (Lopez-Lago et al., 2000; Wu et al., 1995) . Similar results are found when full length Vav proteins with point mutations in the CH domain are used . Since these oncogenic versions lack a functional CH region, it can be inferred that this domain has some eector functions in the generation of Ca 2+¯u xes. It is therefore possible that, in addition to the Rac1 pathway activated by the DH domain of Vav, the CH region works as an adaptor motif allowing the binding of a possible eector of Vav which contributes to PLC-g1 activation and the formation of Ca 2+¯u xes (Figure 2 ). This possible mechanism of action raises interesting questions regarding the regulation of this response. To assure immune homeostasis, a T-cell should activate this Vav-mediated response only when it has been presented with its speci®c antigen. Thus, the possible eector functions of the Vav CH region should be regulated by upstream signals derived from the stimulated TCR. One interesting possibility is to regulate this response by a structural mechanism similar to that used for the modulation of Vav enzyme activity (Aghazadeh et al., 2000) . If so, it is possible that the close con®guration of the DH domain of Vav in the non-phosphorylated state could also induce the association of the CH region with other domains of Vav, blocking its interaction with other eector molecules. During T-cell stimulation, the intramolecular inhibition of the CH region would be released by the phosphorylation of Vav on tyrosine residues. This model is attractive because it would ensure the simultaneous activation of the Rac1 and Ca 2+ signals by Vav. The validity of this regulatory mechanism remains, however, to be tested experimentally.
Another possible interaction between Vav and the NF-AT response is in the regulation of the Ras pathway, a route previously shown to be important for the activation of this transcriptional factor (Ser¯ing et al., 2000; Zhu and McKeon, 2000) . Ras is also important for Vav signaling, since the expression of a dominant negative mutant of Ras inhibits the activation of NF-AT by Vav and Vav2 in lymphocytes (Doody et al., 2000; Wu et al., 1995) . Interestingly, vav (7/7) T-cells have a defective activation of some downstream elements of the Ras pathway, such as ERK2 (Costello et al., 1999) . The Vav pathway leading to ERK2 activation has not been elucidated as yet. However, an interesting possibility is that Vav could activate Ras via PLC-g1, perhaps by stimulating the activity of the diacylglycerol-dependent exchange factor Ras GRP (Ebinu et al., 1998; Lorenzo et al., 2000) ( Figure 2 ). Recent knock-out experiments have indicated that this exchange factor, unlike other Ras GEFs (such as SOS2, Ras GRF1 and Ras GRF2), is essential for T-cell signaling (Dower et al., 2000; E. Santos, personal communication) .
Finally, Vav can aect the activation of these T-cell responses by using signals from the SH3-SH2-SH3 domain. In agreement with this possibility, we have found that a Vav protein lacking the SH3-SH2-SH3 domain and targeted to the plasma membrane by a farnesylation signal is incapable of stimulating NF-AT despite having the CH, DH, PH, and ZF regions intact (unpublished observations). This protein appears to be functional, since it is capable of inducing high levels of transformation in ®broblasts (unpublished observations). The mechanism by which the Vav C-terminus can aect T-cell responses is unknown. However, given the known function of those domains in protein/ protein interactions, it can be assumed that this signal is given by the binding of proline-rich or phosphorylated proteins to Vav during the responses of lymphocytes to antigens (Figure 2) . Interestingly, it has been shown that the ability of Vav family members to activate NF-AT is cell type speci®c. Thus, Vav promotes activation of NF-AT in B-and T-cells while Vav2 is only active on B-cells (Doody et al., 2000) . This cannot be explained in the context of dierences in the CH region, since these domains are very similar in these two proteins. This result adds up an additional level in the complexity of this biological response. It remains to be determined whether this dierential response is mediated by dierent phosphorylation kinetics during TCR signaling, by dierent subcellular localizations in T-cells, or by the binding of dierent adaptor molecules that cooperate in this signal. Interestingly, Vav2 cannot compensate functionally the absence of Vav in both immature and mature T-cells (Doody et al., 2001) , indicating that this dierential response seen with cultured cell lines is probably a good re¯ection of the dierent regulatory or signaling properties of these exchange factors. In summary, the activation of NF-AT by Vav proteins is a highly complex process requiring the simultaneous engagement of adaptor proteins and several signaling pathways regulated by the catalytic and adaptor functions of Vav proteins.
It is not known whether the SH3-SH2-SH3 region of Vav may mediate eector functions in non-hematopoietic tissues. The overexpression of these C-terminal domains leads to a dominant negative eect in T-cells, mast cells, and ®broblasts, probably by blocking the interaction of the autophosphorylated kinases with the endogenous Vav proteins (Arudchandran et al., 2000; Wu et al., 1996; unpublished observations) . However, vav and vav3 genes are known to yield by alternative splicing truncated versions containing only the Cterminal SH3 domain (in the case of Vav) or the SH3-SH2-SH3 region (in the case of Vav3) (Okumura et al., 1997; Trenkle et al., 2000; Zeng et al., 2000;  Figure 1a) . Interestingly, the expression of these proteins does not overlap with the full length proteins (Okumura et al., 1997; Zeng et al., 2000) . These results suggest these other versions of Vav proteins have functional roles of their own, probably by working as adaptor proteins in some speci®c pathways. The availability of cells derived from the knock outs of vav family genes will help to solve in the future the role of the possible functions of the shorter forms of Vav proteins.
Collectively, all these data indicate that Vav proteins have both GEF-dependent and independent functions. The activation of GTPase pathways by Vav seems to be prevalent in non-hematopoietic cells, while lymphoid cells seem to rely more heavily in the combined and synergistic eect of GTPase-dependent and independent pathways. There is also experimental evidence suggesting that the GTPase-independent functions of Vav proteins rely in the association of these exchange factors with other signaling proteins. Given the importance of the generation of Ca 2+ and NF-AT signals in lymphoid development and in immune responses, it is expected that this area of research will be one of the most predominant in the Vav ®eld in the near future.
Role of adaptor proteins in the function of Vav proteins
In addition to the possible adaptor roles of Vav proteins, there is now a large body of data indicating that the signaling pathways of these proteins are highly dependent on the cooperation of other adaptor proteins (Figure 1b Although it was initially thought that the SH2-mediated interaction of Vav proteins was sucient for assuring its phosphorylation by protein tyrosine kinases, it is now known that this process only occurs eciently with the aid of a number of ancillary proteins, at least in the case of hematopoietic cells. These adaptor proteins are membrane receptors or, alternatively, cytoplasmic proteins containing SH2, SH3 or phosphotyrosine residues. In the case of Blymphocytes, both Vav and Vav2 require the interaction with the cytoplasmic tail of the CD19 receptor for optimal tyrosine phosphorylation, a step that facilitates the proximity of these exchange factors with the IgMassociated Syk (Li et al., 1997; O'Rourke et al., 1998; Weng et al., 1994; Figure 3a) . At least in the case of Vav, a second bene®t of this type of complex is the localization of Vav in close proximity to Lyn, a Src family kinase that binds to the cytoplasmic tail of CD19 (Fujimoto et al., 1999) The case of T-lymphocytes is more complex because the optimal phosphorylation of Vav relies in the simultaneous utilization of dierent adaptor molecules. One way of favoring the interaction of Vav with the Tcell speci®c Zap70 kinase is the use of CD28, a receptor stimulated at the same time that the TCR in non anergic T-cell responses (Figure 3a) . In good agreement with such role, the co-engagement of the TCR with CD28 yields levels of Vav tyrosine phosphorylation much higher than when each receptor is cross-linked independently. However, unlike the interaction with CD19, this interaction appears to be established indirectly by using Grb2 as bridge molecule (Kim et al., 1998; Figure 3a) . In this complex, Grb2 binds simultaneously to the phosphorylated tail of the CD28 receptor and the Vav N-terminal SH3 domain using its SH2 domain and C-terminal SH3 domain, respectively (Figure 3a) .
The optimal phosphorylation of Vav is also impaired when the adaptor molecule LAT is missing in T-cells (Finco et al., 1998; Figure 3b) . LAT is an adaptor protein localized in rafts of the plasma membrane rich in cholesterol and glycolipids (Zhang et al., 1998a,b;  see review by Watson, this issue). LAT does not have any recognizable catalytic motifs but contains various tyrosine residues consensus for both the phosphorylation by cytoplasmic kinases and for the binding of SH2 domains (Zhang et al., 1998a,b) . Upon cell stimulation, LAT is phosphorylated by activated Syk/Zap70 proteins on tyrosine residues, leading to the creation of binding sites for SH2-containing proteins (Zhang et al., 1998a) . As a consequence, several SH2/SH3-containing proteins move into these membrane rafts during cell signaling (Zhang et al., 1998a,b) . Since the Vav SH2 domain cannot bind to phosphorylated LAT (Zhang et al., 1998a) , the interaction between these two proteins is probably mediated by Grb2, a molecule that binds to phosphorylated LAT via its SH2 domain (Zhang et al., 1998a ; Figure 3b ). The use of Grb2 for the Vav/LAT and Vav/CD28 interaction is probably a functional stratagem to facilitate the subsequent binding of the unoccupied Vav SH2 domain with the activated, tyrosine phosphorylated Zap70 (Figure 3b) . Despite the type of interaction and adaptor molecule used, the ®nal result is the same: the translocation of Vav proteins to speci®c regions of the plasma membrane where they will be localized close to the upstream kinase. Whether Vav2 and Vav3 utilize CD28 and LAT for the interaction with Zap70 in T-cells is unknown yet.
Current evidence indicates that the role of adaptor proteins in the Vav pathway does not end at the modulation of the phosphorylation levels of Vav protein. Since the result of the interaction of Vav with CD28, CD19, and LAT is to promote the translocation of Vav to lipid rafts, these interactions should promote a more ecient signaling output due to the close (Slp76, see below) . Indeed, the inclusion of a farnesylation signal at the C-terminus of full-length Vav allowing its constitutive localization in the plasma membrane induces the hyperactivation of the NF-AT pathway in T-cells .
It is not clear at present whether there is a functional complex in T-cells similar to the Vav proteins/PIP-5 kinase/CD19 system of B-cells. However, B-and T-cells share another type of regulation of Vav function: its interaction with members of the BLNK/Slp76 family. Slp76 and BLNK are proteins whose structure contains an N-terminal SAM domain, a hydrophilic region with several phosphorylation sites, a proline rich region, and a SH2 domain (for a review, see Koretzky, this issue). Slp76 is a signaling protein expressed in T-and myeloid cells while BLNK is con®ned to B-cells (see review by Koretzky, this issue). Slp76 plays essential roles in Tcell signaling, coupling the activation of the TCR with increases in Ca   2+ , the stimulation of the Ras/MAPK pathway, and the activation of il-2 gene transcription. Similar roles have been attributed to BLNK in B-cell signaling (see Koretzky, this issue) . Since Slp76 and BLNK do not have catalytic domains, their biological functions are due to their interaction with other signaling molecules (see Koretzky, this issue) . In the context of Vav-mediated signaling, it has been shown that the co-expression of Vav with Slp76 induces a synergistic response, leading to enhanced activation of the NF-AT transcriptional activator (Wu et al., 1996) . Interestingly, Vav and Slp76 form a very stable complex during T-cell stimulation, an association mediated by the binding of the Vav SH2 domain to phosphorylated residues located in the acidic domain of Slp76 (Onodera et al., 1996; Raab et al., 1997; Tuosto et al., 1996; Wu et al., 1996) . The role of Slp76 in the Vav pathway remains controversial. It was proposed initially that the function of Slp76 in this interaction was to favor the optimal activation of some of the downstream elements of Rac1 during lymphocyte signaling. According to these results, Slp76 was shown to nucleate a heteromolecular complex composed of the Rac1/Vav and Nck/PAK pairs (Bubeck Wardenburg et al., 1998; Figure 4) . In this complex, Vav and Nck bind via their SH2 domains to dierent phosphotyrosine residues of Slp76. At the same time, Rac1 binds to the DH domain of Vav and PAK to the SH3 domains of Nck. The ®nal outcome of this multimeric complex is the close proximity between activated Rac1 and its eector PAK and, consequently, a more eective stimulation of this kinase during signal transduction (Bubeck Wardenburg et al., 1998; Figure 4) . It should be noted however that recent experiments indicate that the activation of PAK in T-cells is totally independent of the presence of Slp76 (Ku et al., 2001) . Moreover, Koretzky's group has reported that the synergistic response between Vav and Slp76 occurs also with mutants of Slp76 that cannot bind to Vav (Fang and Koretzky, 1999) . Taken together, these results suggest that the function of the Vav/Slp76 complex is not related with the optimal activation of the Rac1/PAK route. There are at least three other possibilities for the cross talk between Vav and Slp76 in the absence of physical association. Thus, Slp76 and Vav converge in the generation of Ca 2+¯u xes by favoring the phosphorylation and activity of PLC-g1, respectively (Costello et al., 1999; Yablonski et al., 1998) . Slp76 and Vav are also important for the stimulation of ERK during T-cell signaling (Costello et al., 1999; Yablonski et al., 1998) . Finally, Vav and Slp76 converge in the translocation and transcriptional activation of NF-AT (Musci et al., 1997; Wu et al., 1996) . The detailed understanding of the Vav/Slp76 synergy will have to wait for the characterization of the Slp76 binding proteins that mediate each of the biological responses attributed to this adaptor protein. In addition to the functional cooperativity with Vav, Slp76 has Vavindependent functions, because the phenotype of slp76-de®cient mice is more severe than the observed in vav (7/7) and vav (7/7)/vav2 (7/7) mice (M Turner, personal communication) . Given the structural similarity between Slp76 and BLNK, it is likely these synergistic pathways are conserved in B-cells.
In addition to the hematopoietic proteins discussed above, there are other ubiquitous proteins forming complexes with Vav proteins. All mammalian Vav proteins can bind to Shc (Movilla and Bustelo, 1999; Zeng et al., 2000) , a known SH2/PTB-containing protein that has been implicated in the Ras pathway (for a review, see Ravichandran, this issue). Shc binds to Vav proteins during the signaling of many membrane protein tyrosine kinases (Movilla and Bustelo, 1999; Zeng et al., 2000) . However, it is not yet known whether this interaction is mediated by the Vav SH2 domain, the SH2/PTB domain of Shc, or indirectly by the simultaneous binding of these two proteins to the autophosphorylated receptor. The functional signi®cance of the Vav/Shc interaction is unknown as yet. Grb2 is also found constitutivelyassociated with Vav proteins in non-hematopoietic cells (Ye and Baltimore, 1994; Zeng et al., 2000) . It is not yet clear the functional implications of the Grb2/Vav association in non-hematopoietic cells. Co-transfection of Grb2 with Vav does not alter the transforming activity of this protein when tested in NIH3T3 cells, indicating that Grb2 has no major eects in the signaling output of these proteins in ®broblasts (unpublished observations). p85, the regulatory subunit of PI3-K has also been shown to associate with Vav3 during the stimulation of a number of non-hematopoietic membrane receptors (Zeng et al., 2000) . However, the precise role of p85 in the pathways of Vav and Vav3 remains to be elucidated.
From what we have seen so far, adaptor proteins exert mostly auxiliary roles in the pathways of Vav proteins. However, at least one human pathogen, the human immunode®ciency virus (HIV), has learnt that the use of adaptor proteins to interfere with the Vav pathway is a good strategy to alter the signaling properties of the host cell for its own bene®t. To this end, the HIV has invented an adaptor protein of its own, the viral Nef protein. Nef is a 27 to 35 kDa myristylated protein essential for optimal viral replication and in the progression to AIDS (Herna Remkema and Saksela, 2000) . This protein appears to have pleiotropic functions. Thus, Nef downmodulates CD4, the TCR/CD3 complex, the major histocompatibility class I antigens, and the CD28 co-receptor on the surface of infected cells (Skowronski et al., 1999; Swigut et al., 2001) . These actions are mediated by the interaction of Nef with the endocytic machinery of the host cell (Skowronski et al., 1999) . Nef also aects apoptotic pathways, both by inducing the Fasmediated killing of non infected cells and by inhibiting the apoptotic response in the host cell (Roshal et al., 2001) . Finally, Nef perturbs the signaling responses of the host cells including, among others, the stimulation of tyrosine kinases, GTPases (Rac1 and Cdc42), and serine/threonine kinases (PAK) (Herna Remkema and Saksela, 2000) . The result of this interference is the generation of cytoskeletal changes (Fackler et al., 1999) , enhanced calcium signaling (Manninen et al., 2000) , and activation of transcriptional factors such as NF-AT (Manninen et al., 2000) . The perturbation of these signaling pathways appear to be due to the work of Nef as a truly adaptor protein. Thus, a proline-rich region present in the N-terminus of Nef can form complexes with tyrosine kinases of the Src family, leading to enhanced kinase activities (Briggs et al., 1997) . What it is more important for us in this review, Nef also nucleates a Slp76-like complex in T-cells that leads to activation of PAK1 by Vav/Rac1 (Fackler et al., 1999 (Fackler et al., , 2000  Figure 4 ). To accomplish this, Nef binds via its proline-rich region to the C-terminal SH3 domain of Vav and, simultaneously, to PAK using the Nef diarginine motif (Fackler et al., 1999 (Fackler et al., , 2000 . The outcome of this complex is the close proximity of Vav/ Rac1 to PAK1, inducing the ecient activation of this kinase (Fackler et al., 1999 (Fackler et al., , 2000  Figure 4 ). In addition, Nef seems to activate the exchange activity of Vav, probably by driving this molecule to the plasma membrane (Fackler et al., 1999) . Thus, in this case, an adaptor protein is used to mimic the normal cycle of Vav during cell stimulation, allowing the activation of this protein even when the upstream receptors have been downmodulated by the virus.
It can be inferred from what we have summarized in these pages that we have now a much better understanding of the function of Vav proteins during cell signaling. However, many interesting questions remain, especially in regard to the GEF-independent functions of Vav proteins and the precise role of the adaptor proteins that bind to them during cell signaling. We will need to clarify also the cross-talk probably existing between the GEF-dependent and independent routes triggered by Vav proteins. Ultimately, the elucidation of all these pending questions will allow to have a precise knowledge of the multiple regulatory and eector steps mediating the signaling of membrane receptors coupled to tyrosine kinase pathways.
